Allergologie select, Volume 5 (2021) - 1st Issue (72 - 76)

Practical recommendations for the allergological risk assessment of the COVID-19 vaccination – a harmonized statement of allergy centers in Germany
Margitta Worm1, Andrea Bauer2, Bettina Wedi3, Regina Treudler4, Wolfgang Pfuetzner5, Knut Brockow6, Timo Buhl7, Torsten Zuberbier8, Joachim Fluhr8, Gerda Wurpts9, Ludger Klimek10, Thilo Jakob11, Hans F. Merk12, Norbert Mülleneisen13, Stefani Roeseler14, Heinrich Dickel15, Ulrike Raap16, Jörg Kleine-Tebbe17
1 Allergology and Immunology, Department of Dermatology, Venereology and Allergology, Campus Charité Mitte, University Medicine Berlin, 2 Clinic and Polyclinic for Dermatology, University Hospital Carl Gustav Carus at the Technical University Dresden, 3 Department of Dermatology, Allergology and Venereology Comprehensive Allergy Center (CAC) Treatment Center for Hereditary Angioedema in the ZSE, Hannover Medical School, 4 Clinic of Dermatology, Venereology and Allergology, Leipzig University Medical Center, 5 Hesse Allergy Center, Clinic for Dermatology and Allergology, Marburg University Hospital, 6 Dermatology Clinic Campus Biederstein, Klinikum rechts der Isar, Technical University of Munich, 7 Dermatology Venereology and Allergology Clinic, University Medical Center Göttingen Georg-August-University, 8 Department of Dermatology and Allergy, Comprehensive Allergy Center Charité – Universitätsmedizin Berlin, Germany, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, 9 Department of Dermatology and Allergology, University Hospital Aachen, 1  0 Center for Rhinology and Allergology of the ENT University Clinic Mannheim, Wiesbaden, 1  1 Department of Dermatology, Venerology and Allergology, University Hospital Giessen, 1  2 Dermatology Clinic, RWTH Aachen University, 1  3 Asthma and Allergy Center, Leverkusen, 1  4 Allergy, Asthma and Anaphylaxis Center, Clinic of Pneumology, Allergology, Sleep and Respiratory Medicine, Augustinians Hospital, Cologne, 1  5 Department of Allergology, Occupational and Environmental Dermatology, Clinic for Dermatology, Venereology and Allergology, St. Josef Hospital, Ruhr University Bochum, 1  6 Department of Experimental Allergology and Immunodermatology, Department of Human Medicine, University of Oldenburg, and 1  7 Allergy and Asthma Center Westend, Berlin, Germany

   

 

DOI 10.5414/ALX02225E

Abstract

Severe allergic reactions to vaccines are very rare. Single severe reactions have occurred worldwide after vaccination with the new mRNA-based COVID-19 vaccines. PEG2000 is discussed as a possible trigger. We provide guidance on risk assessment regarding COVID-19 vaccination in patients with allergic diseases and suggest a standardized, resource-oriented diagnostic and therapeutic procedure. Reports of severe allergic reactions in the context of COVID-19 vaccination can be made via www.anaphylaxie.net using an online questionnaire.

Author Details

Authors

Departments

  • 1 Allergology and Immunology, Department of Dermatology, Venereology and Allergology, Campus Charité Mitte, University Medicine Berlin,
  • 2 Clinic and Polyclinic for Dermatology, University Hospital Carl Gustav Carus at the Technical University Dresden,
  • 3 Department of Dermatology, Allergology and Venereology Comprehensive Allergy Center (CAC) Treatment Center for Hereditary Angioedema in the ZSE, Hannover Medical School,
  • 4 Clinic of Dermatology, Venereology and Allergology, Leipzig University Medical Center,
  • 5 Hesse Allergy Center, Clinic for Dermatology and Allergology, Marburg University Hospital,
  • 6 Dermatology Clinic Campus Biederstein, Klinikum rechts der Isar, Technical University of Munich,
  • 7 Dermatology Venereology and Allergology Clinic, University Medical Center Göttingen Georg-August-University,
  • 8 Department of Dermatology and Allergy, Comprehensive Allergy Center Charité – Universitätsmedizin Berlin, Germany, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health,
  • 9 Department of Dermatology and Allergology, University Hospital Aachen,
  • 1 
  • 0 Center for Rhinology and Allergology of the ENT University Clinic Mannheim, Wiesbaden,
  • 1 
  • 1 Department of Dermatology, Venerology and Allergology, University Hospital Giessen,
  • 1 
  • 2 Dermatology Clinic, RWTH Aachen University,
  • 1 
  • 3 Asthma and Allergy Center, Leverkusen,
  • 1 
  • 4 Allergy, Asthma and Anaphylaxis Center, Clinic of Pneumology, Allergology, Sleep and Respiratory Medicine, Augustinians Hospital, Cologne,
  • 1 
  • 5 Department of Allergology, Occupational and Environmental Dermatology, Clinic for Dermatology, Venereology and Allergology, St. Josef Hospital, Ruhr University Bochum,
  • 1 
  • 6 Department of Experimental Allergology and Immunodermatology, Department of Human Medicine, University of Oldenburg, and
  • 1 
  • 7 Allergy and Asthma Center Westend, Berlin, Germany

Address

Univ.-Prof. Dr. med. Margitta Worm, Charité – Universitätsmedizin Berlin, Allergologie und Immunologie, Klinik für Dermatologie und Allergologie, Charitéplatz 1, 10117 Berlin
Email: [email protected]

Citation

Margitta Worm, Andrea Bauer, Bettina Wedi, Regina Treudler, Wolfgang Pfuetzner, Knut Brockow, Timo Buhl, Torsten Zuberbier, Joachim Fluhr, Gerda Wurpts, Ludger Klimek, Thilo Jakob, Hans F. Merk, Norbert Mülleneisen, Stefani Roeseler, Heinrich Dickel, Ulrike Raap, and Jörg Kleine-Tebbe.Practical recommendations for the allergological risk assessment of the COVID-19 vaccination – a harmonized statement of allergy centers in Germany. 2021; 5: 72-76. doi: 10.5414/ALX02225E.

###article_not_exists_msg###

Warenkorb Übersicht

Warenkorb Übersicht
Typ Anz Rabatt MwSt Preis
Der Warenkorb ist leer
Ihr Warenkorb